|
|
phospholipid translocation
|
GO:0045332 |
2 |
0.684
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.479
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.375
|
Human Mouse |
|
|
post embryonic development
|
GO:0009791 |
2 |
0.230
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
52 |
0.220
|
|
|
|
organic anion transport
|
GO:0015711 |
103 |
0.220
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.215
|
Human Mouse |
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.202
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.202
|
|
|
|
lipid translocation
|
GO:0034204 |
2 |
0.201
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.201
|
Human Mouse |
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.199
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
101 |
0.199
|
Human Rat |
|
|
maintenance of location
|
GO:0051235 |
112 |
0.185
|
|
|
|
anion transport
|
GO:0006820 |
161 |
0.180
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.178
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.173
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.170
|
Human |
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.169
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.164
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.163
|
|
|
|
organophosphate ester transport
|
GO:0015748 |
32 |
0.159
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.159
|
Human Mouse |
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.150
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.150
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.138
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.135
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.126
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.126
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.125
|
|
|
|
histone serine phosphorylation
|
GO:0035404 |
4 |
0.123
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.123
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.122
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.119
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.119
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.116
|
Human |
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.116
|
|
|
|
replicative cell aging
|
GO:0001302 |
3 |
0.115
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.114
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.113
|
Human |
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.109
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.107
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
106 |
0.106
|
Human Rat |
|
|
female gamete generation
|
GO:0007292 |
2 |
0.105
|
|
|
|
muscle contraction
|
GO:0006936 |
73 |
0.103
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.103
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
47 |
0.102
|
Human |
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.102
|
Human |
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.102
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.102
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
65 |
0.102
|
Human Mouse |
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.102
|
Human |
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.101
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.099
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.097
|
Human Mouse |
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
85 |
0.096
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.095
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
87 |
0.091
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.091
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.086
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.086
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.084
|
|
|
|
striated muscle contraction
|
GO:0006941 |
52 |
0.084
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.084
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.084
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.083
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.080
|
|
|
|
transcription from rna polymerase iii promoter
|
GO:0006383 |
19 |
0.079
|
|
|
|
growth
|
GO:0040007 |
202 |
0.079
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.077
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.077
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.077
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
82 |
0.075
|
|
|
|
memory
|
GO:0007613 |
3 |
0.074
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
53 |
0.073
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.072
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.070
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.069
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.069
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
123 |
0.069
|
|
|
|
regulation of system process
|
GO:0044057 |
101 |
0.068
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.065
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.065
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.064
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.063
|
Human |
|
|
muscle system process
|
GO:0003012 |
81 |
0.063
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.063
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
97 |
0.062
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.062
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.061
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
38 |
0.061
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.060
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
107 |
0.060
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.060
|
|
|
|
system process
|
GO:0003008 |
349 |
0.060
|
|
|
|
chronological cell aging
|
GO:0001300 |
2 |
0.059
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061419 |
2 |
0.058
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.058
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.058
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.058
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.058
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.057
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.057
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.056
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.056
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.056
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
152 |
0.054
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.051
|
Human |
|
|
histone modification
|
GO:0016570 |
251 |
0.050
|
|
|
|
skeletal muscle tissue growth
|
GO:0048630 |
2 |
0.050
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
73 |
0.050
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
13 |
0.050
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
87 |
0.050
|
Human Mouse |
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.049
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
84 |
0.049
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.049
|
Human |
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.049
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.049
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.049
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.049
|
|
|
|
negative regulation of cysteine type endopeptidase activity
|
GO:2000117 |
48 |
0.049
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.048
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
17 |
0.048
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.048
|
|
|
|
positive regulation of growth
|
GO:0045927 |
58 |
0.047
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.047
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.047
|
|
|
|
lipid localization
|
GO:0010876 |
106 |
0.047
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.047
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.046
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.046
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
16 |
0.046
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.046
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.046
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.046
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.045
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.045
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.045
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.045
|
|
|
|
phospholipid transport
|
GO:0015914 |
23 |
0.045
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.045
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
101 |
0.045
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.044
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.044
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.044
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.044
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.044
|
Human |
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.044
|
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
20 |
0.044
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.043
|
|
|
|
negative regulation of lipid transport
|
GO:0032369 |
18 |
0.043
|
|
|
|
lipid transport
|
GO:0006869 |
90 |
0.043
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.041
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
24 |
0.041
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.041
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.041
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.040
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.040
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.040
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.040
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.040
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.040
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.040
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
64 |
0.040
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.039
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.039
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.039
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.039
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.039
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.039
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.038
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.038
|
|
|
|
cell aging
|
GO:0007569 |
52 |
0.038
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
3 |
0.038
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.038
|
|
|
|
somatic muscle development
|
GO:0007525 |
1 |
0.037
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
117 |
0.037
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.037
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.037
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.037
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.037
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.036
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.036
|
Human |
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.036
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.036
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.036
|
Human |
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.035
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.035
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.035
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.035
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.035
|
|
|
|
positive regulation of hormone biosynthetic process
|
GO:0046886 |
4 |
0.035
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.035
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.035
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.034
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.034
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.034
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.034
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.034
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.033
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.033
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.033
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.033
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.033
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.033
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
101 |
0.033
|
|
|
|
positive regulation of transcription from rna polymerase iii promoter
|
GO:0045945 |
10 |
0.033
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
27 |
0.032
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.032
|
Human |
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.032
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
99 |
0.032
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.032
|
Human |
|
|
protein acetylation
|
GO:0006473 |
116 |
0.032
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
91 |
0.032
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.031
|
|
|
|
regulation of phospholipid transport
|
GO:2001138 |
4 |
0.031
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.031
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.031
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.031
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.031
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.031
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to oxidative stress
|
GO:0043619 |
5 |
0.031
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.030
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.030
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.030
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
59 |
0.030
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.030
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.030
|
Human |
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.030
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.030
|
Human |
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.029
|
|
|
|
epithelium migration
|
GO:0090132 |
119 |
0.029
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
158 |
0.029
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
68 |
0.029
|
|
|
|
response to insulin
|
GO:0032868 |
45 |
0.029
|
Human |
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.029
|
Human |
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.029
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.029
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
2 |
0.028
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
38 |
0.028
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0043618 |
17 |
0.028
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
122 |
0.028
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.028
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.028
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
128 |
0.028
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
146 |
0.028
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.028
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.027
|
Human |
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.027
|
|
|
|
positive regulation of cell size
|
GO:0045793 |
3 |
0.027
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.027
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.027
|
|
|
|
positive regulation of phospholipid transport
|
GO:2001140 |
4 |
0.027
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
4 |
0.027
|
|
|
|
response to starvation
|
GO:0042594 |
59 |
0.027
|
Human |
|
|
pyruvate metabolic process
|
GO:0006090 |
26 |
0.027
|
Human Mouse |
|
|
regulation of anion transport
|
GO:0044070 |
25 |
0.027
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.027
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.027
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.027
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
72 |
0.026
|
|
|
|
regulation of response to osmotic stress
|
GO:0047484 |
3 |
0.026
|
|
|
|
negative regulation of signal transduction in absence of ligand
|
GO:1901099 |
16 |
0.026
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.026
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.026
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.026
|
Human |
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.026
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.026
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.026
|
|
|
|
axon cargo transport
|
GO:0008088 |
2 |
0.025
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.025
|
Human |
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.025
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.025
|
|
|
|
cellular response to starvation
|
GO:0009267 |
58 |
0.025
|
Human |
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.025
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.025
|
|
|
|
negative regulation of ion transport
|
GO:0043271 |
39 |
0.025
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.025
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.025
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.025
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.025
|
|
|
|
fibroblast activation
|
GO:0072537 |
3 |
0.024
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
12 |
0.024
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.024
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.024
|
|
|
|
regulation of glucose import
|
GO:0046324 |
21 |
0.024
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.024
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
51 |
0.024
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.024
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.024
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.024
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.024
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.024
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.024
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
92 |
0.024
|
|
|
|
regulation of myeloid leukocyte mediated immunity
|
GO:0002886 |
4 |
0.023
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
97 |
0.023
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.023
|
|
|
|
histone acetylation
|
GO:0016573 |
93 |
0.023
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.023
|
Human |
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.023
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.023
|
|
|
|
response to virus
|
GO:0009615 |
126 |
0.023
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.023
|
|
|
|
regulation of muscle organ development
|
GO:0048634 |
27 |
0.023
|
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.023
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.023
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.023
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.023
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.023
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.023
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.023
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.023
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.023
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.022
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
51 |
0.022
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
207 |
0.022
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.022
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
56 |
0.022
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
26 |
0.022
|
|
|
|
regulation of wound healing
|
GO:0061041 |
56 |
0.022
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
52 |
0.022
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.022
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.022
|
Human |
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.022
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.022
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
69 |
0.022
|
|
|
|
response to osmotic stress
|
GO:0006970 |
17 |
0.021
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.021
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.021
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
4 |
0.021
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.021
|
|
|
|
response to peptide
|
GO:1901652 |
65 |
0.021
|
Human |
|
|
epidermis morphogenesis
|
GO:0048730 |
3 |
0.021
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.021
|
|
|
|
hexose metabolic process
|
GO:0019318 |
55 |
0.021
|
|
|
|
translation
|
GO:0006412 |
132 |
0.021
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.021
|
|
|
|
response to nutrient
|
GO:0007584 |
20 |
0.021
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.021
|
|
|
|
developmental growth
|
GO:0048589 |
48 |
0.021
|
|
|
|
response to electrical stimulus
|
GO:0051602 |
1 |
0.021
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
60 |
0.021
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.021
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.021
|
Human |
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.020
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.020
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
81 |
0.020
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.020
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.020
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.020
|
|
|
|
regulation of autophagy
|
GO:0010506 |
52 |
0.020
|
|
|
|
skeletal muscle contraction
|
GO:0003009 |
16 |
0.020
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
72 |
0.020
|
Human |
|
|
regulation of mesonephros development
|
GO:0061217 |
3 |
0.020
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.020
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.020
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.020
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
110 |
0.020
|
|
|
|
histone h2a phosphorylation
|
GO:1990164 |
3 |
0.020
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.020
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
116 |
0.020
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
18 |
0.020
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.020
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
44 |
0.020
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
41 |
0.019
|
Human |
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.019
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.019
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.019
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
34 |
0.019
|
|
|
|
vacuole organization
|
GO:0007033 |
44 |
0.019
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
79 |
0.019
|
|
|
|
camp metabolic process
|
GO:0046058 |
61 |
0.019
|
|
|
|
musculoskeletal movement
|
GO:0050881 |
17 |
0.019
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
109 |
0.019
|
|
|
|
hematopoietic stem cell differentiation
|
GO:0060218 |
4 |
0.019
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.019
|
|
|
|
associative learning
|
GO:0008306 |
1 |
0.019
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.019
|
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
82 |
0.019
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.019
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
132 |
0.019
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.019
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.019
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.019
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
57 |
0.019
|
|
|
|
positive regulation of branching involved in ureteric bud morphogenesis
|
GO:0090190 |
2 |
0.019
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.019
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.019
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.019
|
|
|
|
aging
|
GO:0007568 |
66 |
0.018
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
50 |
0.018
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.018
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.018
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.018
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.018
|
|
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.018
|
|
|
|
regulation of histone modification
|
GO:0031056 |
47 |
0.018
|
|
|
|
regulation of endothelial cell differentiation
|
GO:0045601 |
4 |
0.018
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.018
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.018
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.018
|
|
|
|
coenzyme biosynthetic process
|
GO:0009108 |
24 |
0.018
|
Human Mouse |
|
|
histone h2a s1 phosphorylation
|
GO:0043990 |
1 |
0.018
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.018
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.018
|
|
|
|
myoblast fusion
|
GO:0007520 |
1 |
0.018
|
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.018
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.018
|
|
|
|
regulation of growth rate
|
GO:0040009 |
1 |
0.018
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.018
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
22 |
0.018
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.018
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.018
|
|
|
|
negative regulation of monocyte differentiation
|
GO:0045656 |
3 |
0.018
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.018
|
|
|
|
positive regulation of nf kappab transcription factor activity
|
GO:0051092 |
81 |
0.018
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.018
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.017
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
72 |
0.017
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.017
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.017
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.017
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
85 |
0.017
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.017
|
|
|
|
negative regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043154 |
46 |
0.017
|
|
|
|
tissue migration
|
GO:0090130 |
119 |
0.017
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.017
|
|
|
|
spinal cord development
|
GO:0021510 |
4 |
0.017
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.017
|
|
|
|
muscle cell migration
|
GO:0014812 |
19 |
0.017
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
97 |
0.017
|
Human |
|
|
nuclear transport
|
GO:0051169 |
179 |
0.017
|
|
|
|
negative regulation of lipid biosynthetic process
|
GO:0051055 |
22 |
0.017
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
136 |
0.017
|
|
|
|
positive regulation of response to external stimulus
|
GO:0032103 |
88 |
0.017
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.017
|
|
|
|
leukocyte migration
|
GO:0050900 |
107 |
0.017
|
|
|
|
dicarboxylic acid biosynthetic process
|
GO:0043650 |
4 |
0.017
|
|
|
|
regulation of axon guidance
|
GO:1902667 |
3 |
0.016
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
74 |
0.016
|
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
38 |
0.016
|
Human Mouse |
|
|
secretion by cell
|
GO:0032940 |
226 |
0.016
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
56 |
0.016
|
Human |
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.016
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
3 |
0.016
|
|
|
|
regulation of response to drug
|
GO:2001023 |
3 |
0.016
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
128 |
0.016
|
|
|
|
actin filament based movement
|
GO:0030048 |
17 |
0.016
|
|
|
|
viral life cycle
|
GO:0019058 |
132 |
0.016
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.016
|
|
|
|
response to axon injury
|
GO:0048678 |
1 |
0.016
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.016
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.016
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
3 |
0.016
|
|
|
|
response to alcohol
|
GO:0097305 |
64 |
0.016
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
22 |
0.016
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.016
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.016
|
|
|
|
urea metabolic process
|
GO:0019627 |
3 |
0.016
|
|
|
|
vasodilation
|
GO:0042311 |
4 |
0.016
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.016
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.016
|
|
|
|
regulation of histone acetylation
|
GO:0035065 |
19 |
0.015
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.015
|
|
|
|
histone phosphorylation
|
GO:0016572 |
16 |
0.015
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.015
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.015
|
|
|
|
mitochondrial membrane organization
|
GO:0007006 |
40 |
0.015
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
2 |
0.015
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
4 |
0.015
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
158 |
0.015
|
|
|
|
carbohydrate transport
|
GO:0008643 |
37 |
0.015
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
4 |
0.015
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.015
|
|
|
|
negative regulation of alpha beta t cell activation
|
GO:0046636 |
3 |
0.015
|
|
|
|
patterning of blood vessels
|
GO:0001569 |
2 |
0.015
|
|
|
|
regulation of sphingolipid biosynthetic process
|
GO:0090153 |
2 |
0.015
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.015
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.015
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.015
|
|
|
|
plasma membrane organization
|
GO:0007009 |
115 |
0.015
|
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
3 |
0.015
|
|
|
|
response to nitric oxide
|
GO:0071731 |
4 |
0.015
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
132 |
0.015
|
|
|
|
chemical homeostasis within a tissue
|
GO:0048875 |
3 |
0.015
|
|
|
|
regulation of transmembrane transporter activity
|
GO:0022898 |
74 |
0.015
|
|
